Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
J Neuroimaging ; 17(4): 286-91, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17894614

ABSTRACT

BACKGROUND AND PURPOSE: Reports of central pontine myelinolysis (CPM)-like changes in Wilson's disease (WD) and its sequential changes are exceptional. The aim was to study the MRI characteristics of CPM-like changes in WD and the serial changes. METHODS: Among the 121 patients of WD, twenty (M:F:9:11, age at onset: 14.2 +/- 4.6 years) had features similar to CPM. All had progressive neuropsychiatric form of WD. All except five were on de-coppering treatment. None had acute deterioration or hepatic failure. Ten patients underwent repeat studies. RESULTS: Twenty patients with CPM-like changes manifested with characteristic phenotype of WD. Three distinct patterns of CPM-like changes were observed: (a) characteristic round shape -7, (b) "bisected" -9, and (c) "trisected" -4. Only one had signal changes suggesting extra-pontine myelinolysis. All patients had contiguous involvement of midbrain. Serial MRI evaluation in 10 patients, at mean interval period of 17.4 +/- 13.2 months, revealed complete reversal in one, partial improvement in five, and no change in three. Clinical and MRI improvement occurred pari passu, except in one. CONCLUSIONS: CPM-like changes in WD are perhaps under-recognized and are distinct from the commonly known "osmotic demyelination." It is potentially reversible similar to other MRI features of WD.


Subject(s)
Chelating Agents/therapeutic use , Hepatolenticular Degeneration/drug therapy , Hepatolenticular Degeneration/pathology , Magnetic Resonance Imaging/methods , Pons/pathology , Adolescent , Adult , Astringents/therapeutic use , Chi-Square Distribution , Child , Disease Progression , Female , Health Status Indicators , Humans , India , Male , Penicillamine/therapeutic use , Phenotype , Prognosis , Prospective Studies , Zinc Sulfate/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...